Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-May-13 6:03 PM View:  | Baker Felix Director 10% Owner | Genomic Health Inc. (GHDX) | 16-May-13 | Market Purchase | 19,306 | $36.54 | $705,426.00 | < 1% 23.9M to 23.92M | (< 1%) |
| 17-May-13 5:33 PM View: | Livingston Randall S Director | Genomic Health Inc. (GHDX) | 15-May-13 | Market Option Sale | 1,337 | $35.83 | $47,903.50 | (18%) 7.49K to 6.15K | (2%) |
| 16-May-13 6:03 PM View: | Baker Felix Director 10% Owner | Genomic Health Inc. (GHDX) | 15-May-13 | Market Purchase | 52,133 | $36.41 | $1,898,360.00 | < 1% 23.85M to 23.9M | (< 1%) |
| 17-May-13 5:33 PM View: | Livingston Randall S Director | Genomic Health Inc. (GHDX) | 15-May-13 | Option Exercise | 1,337 | $1.33 | $1,773.66 | 22% 6.15K to 7.49K | |
| 14-May-13 6:40 PM View: | Baker Felix Director 10% Owner | Genomic Health Inc. (GHDX) | 14-May-13 | Market Purchase | 27,184 | $35.53 | $965,899.00 | < 1% 25.24M to 25.27M | (2%) |
| 15-May-13 6:08 PM View: | Popovits Kimberly J President and CEO Director | Genomic Health Inc. (GHDX) | 13-May-13 | Option Exercise | 5,000 | $2.88 | $14,400.00 | 2% 252.44K to 257.44K | |
| 15-May-13 6:10 PM View: | Hibbs Kathy L SVP & General Counsel | Genomic Health Inc. (GHDX) | 13-May-13 | Option Exercise | 1,250 | $21.07 | $26,337.50 | 18% 7.09K to 8.34K | |
| 14-May-13 6:40 PM View: | Baker Felix Director 10% Owner | Genomic Health Inc. (GHDX) | 13-May-13 | Market Purchase | 213,242 | $34.19 | $7,291,170.00 | < 1% 25.03M to 25.24M | 2% |
| 15-May-13 6:10 PM View: | Hibbs Kathy L SVP & General Counsel | Genomic Health Inc. (GHDX) | 13-May-13 | Market Option Sale | 1,250 | $34.42 | $43,031.00 | (15%) 8.34K to 7.09K | (3%) |
| 15-May-13 6:08 PM View: | Popovits Kimberly J President and CEO Director | Genomic Health Inc. (GHDX) | 13-May-13 | Market Option Sale | 5,000 | $34.70 | $173,506.00 | (2%) 257.44K to 252.44K | (2%) |
| 13-May-13 5:33 PM View: | Schorno Dean L CFO | Genomic Health Inc. (GHDX) | 09-May-13 | Option Exercise | 4,000 | $17.18 | $68,720.00 | 17% 23.24K to 27.24K | |
| 13-May-13 5:33 PM View: | Schorno Dean L CFO | Genomic Health Inc. (GHDX) | 09-May-13 | Market Option Sale | 4,000 | $36.02 | $144,088.00 | (15%) 27.24K to 23.24K | 4% |
| 09-May-13 3:16 PM View: | Cole G Bradley COO | Genomic Health Inc. (GHDX) | 08-May-13 | Option Exercise | 2,500 | $1.33 | $3,325.00 | 20% 12.54K to 15.04K | |
| 09-May-13 3:16 PM View: | Cole G Bradley COO | Genomic Health Inc. (GHDX) | 08-May-13 | Market Option Sale | 2,500 | $35.99 | $89,964.00 | (17%) 15.04K to 12.54K | (< 1%) |
| 25-Apr-13 5:55 PM View: | Popovits Kimberly J President and CEO Director | Genomic Health Inc. (GHDX) | 23-Apr-13 | Market Option Sale | 2,500 | $30.00 | $75,000.00 | (< 1%) 254.94K to 252.44K | < 1% |
| 25-Apr-13 5:55 PM View: | Popovits Kimberly J President and CEO Director | Genomic Health Inc. (GHDX) | 23-Apr-13 | Option Exercise | 2,500 | $2.88 | $7,200.00 | < 1% 252.44K to 254.94K | |
| 05-Apr-13 5:50 PM View: | Cole G Bradley COO | Genomic Health Inc. (GHDX) | 03-Apr-13 | Market Option Sale | 2,500 | $27.79 | $69,483.00 | (17%) 15.04K to 12.54K | 2% |
| 05-Apr-13 5:50 PM View: | Cole G Bradley COO | Genomic Health Inc. (GHDX) | 03-Apr-13 | Option Exercise | 2,500 | $1.33 | $3,325.00 | 20% 12.54K to 15.04K | |
| 03-Apr-13 5:50 PM View: | Baker Felix Director 10% Owner | Genomic Health Inc. (GHDX) | 01-Apr-13 | Grant | 4,284 | $27.99 | $119,909.00 | < 1% 12.76M to 12.76M | (< 1%) |
| 03-Apr-13 4:56 PM View: | Graham Ginger L Director | Genomic Health Inc. (GHDX) | 01-Apr-13 | Grant Duplicate | 357 | $27.99 | $9,992.43 | 12% 2.89K to 3.25K | (< 1%) |
| 03-Apr-13 4:55 PM View: | Cohen Fred E Director | Genomic Health Inc. (GHDX) | 01-Apr-13 | Grant | 357 | $27.99 | $9,992.43 | < 1% 66.03K to 66.38K | (< 1%) |
| 03-Apr-13 4:54 PM View: | Colella Samuel D Director | Genomic Health Inc. (GHDX) | 01-Apr-13 | Grant | 357 | $27.99 | $9,992.43 | < 1% 57.24K to 57.6K | (< 1%) |
| 03-Apr-13 4:53 PM View: | Myers Woodrow A Jr Director | Genomic Health Inc. (GHDX) | 01-Apr-13 | Grant | 357 | $27.99 | $9,992.43 | 12% 2.89K to 3.25K | (< 1%) |
| 08-Mar-13 4:14 PM View: | Cole G Bradley COO | Genomic Health Inc. (GHDX) | 06-Mar-13 | Option Exercise | 2,500 | $1.33 | $3,325.00 | 20% 12.54K to 15.04K | |
| 08-Mar-13 4:14 PM View: | Cole G Bradley COO | Genomic Health Inc. (GHDX) | 06-Mar-13 | Market Option Sale | 2,500 | $28.57 | $71,435.00 | (17%) 15.04K to 12.54K | (1%) |
| 21-Feb-13 6:11 PM View: | Baker Felix Director 10% Owner | Genomic Health Inc. (GHDX) | 21-Feb-13 | Market Purchase | 28,200 | $27.64 | $779,359.00 | < 1% 23.29M to 23.31M | 2% |
| 21-Feb-13 6:11 PM View: | Baker Felix Director 10% Owner | Genomic Health Inc. (GHDX) | 20-Feb-13 | Market Purchase | 20,885 | $27.97 | $584,220.00 | < 1% 23.26M to 23.29M | < 1% |
| 22-Feb-13 7:50 PM View: | Hibbs Kathy L SVP & General Counsel | Genomic Health Inc. (GHDX) | 20-Feb-13 | Market Sale | 2,716 | $28.13 | $76,399.20 | (28%) 9.8K to 7.09K | < 1% |
| 20-Feb-13 7:19 PM View: | Hibbs Kathy L SVP & General Counsel | Genomic Health Inc. (GHDX) | 15-Feb-13 | Payment of Exercise | 1,850 | $28.77 | $53,224.50 | (16%) 11.37K to 9.52K | (29%) |
| 20-Feb-13 7:27 PM View: | Shak Steven EVP of R&D & CMO | Genomic Health Inc. (GHDX) | 15-Feb-13 | Payment of Exercise | 1,388 | $28.77 | $39,932.80 | (< 1%) 333.77K to 332.38K | (29%) |
| 20-Feb-13 7:33 PM View: | Cole G Bradley COO | Genomic Health Inc. (GHDX) | 15-Feb-13 | Payment of Exercise | 1,819 | $28.77 | $52,332.60 | (13%) 14.09K to 12.27K | (29%) |
| 20-Feb-13 7:22 PM View: | Schorno Dean L CFO | Genomic Health Inc. (GHDX) | 15-Feb-13 | Payment of Exercise | 1,141 | $28.77 | $32,826.60 | (5%) 23.5K to 22.36K | (29%) |
| 20-Feb-13 7:45 PM View: | Popovits Kimberly J President and CEO Director | Genomic Health Inc. (GHDX) | 15-Feb-13 | Payment of Exercise | 2,560 | $28.77 | $73,651.20 | (1%) 255.0K to 252.44K | (29%) |
| 14-Feb-13 5:51 PM View: | Baker Felix Director 10% Owner | Genomic Health Inc. (GHDX) | 14-Feb-13 | Market Purchase | 34,800 | $28.43 | $989,402.00 | < 1% 23.18M to 23.21M | 1% |
| 15-Feb-13 7:32 PM View: | Myers Woodrow A Jr Director | Genomic Health Inc. (GHDX) | 14-Feb-13 | Option Exercise | 41,250 | $18.88 | $778,635.00 | 1427% 2.89K to 44.14K | |
| 15-Feb-13 7:32 PM View: | Myers Woodrow A Jr Director | Genomic Health Inc. (GHDX) | 14-Feb-13 | Market Option Sale | 41,250 | $28.40 | $1,171,530.00 | (93%) 44.14K to 2.89K | (1%) |
| 14-Feb-13 5:51 PM View: | Baker Felix Director 10% Owner | Genomic Health Inc. (GHDX) | 13-Feb-13 | Market Purchase | 17,200 | $28.58 | $491,585.00 | < 1% 23.16M to 23.18M | < 1% |
| 25-Apr-13 5:55 PM View: | Popovits Kimberly J President and CEO Director | Genomic Health Inc. (GHDX) | 12-Feb-13 | Gift | 974 | -- | -- | < 1% 252.44K to 253.41K | |
| 25-Apr-13 5:55 PM View: | Popovits Kimberly J President and CEO Director | Genomic Health Inc. (GHDX) | 12-Feb-13 | Gift | 974 | -- | -- | (< 1%) 253.41K to 252.44K | |
| 11-Feb-13 6:43 PM View: | Baker Felix Director 10% Owner | Genomic Health Inc. (GHDX) | 11-Feb-13 | Market Purchase | 79,984 | $28.23 | $2,258,080.00 | < 1% 23.0M to 23.08M | 2% |
| 11-Feb-13 6:43 PM View: | Baker Felix Director 10% Owner | Genomic Health Inc. (GHDX) | 08-Feb-13 | Market Purchase | 36,376 | $27.96 | $1,017,110.00 | < 1% 22.96M to 23.0M | 3% |
| 07-Feb-13 5:02 PM View: | Cole G Bradley COO | Genomic Health Inc. (GHDX) | 06-Feb-13 | Market Option Sale | 2,500 | $28.03 | $70,076.20 | (15%) 16.59K to 14.09K | (3%) |
| 07-Feb-13 5:02 PM View: | Cole G Bradley COO | Genomic Health Inc. (GHDX) | 06-Feb-13 | Option Exercise | 2,500 | $1.33 | $3,325.00 | 18% 14.09K to 16.59K | |
| 29-Jan-13 5:22 PM View: | Livingston Randall S Director | Genomic Health Inc. (GHDX) | 28-Jan-13 | Option Exercise | 2,000 | $1.33 | $2,653.20 | 33% 6.15K to 8.15K | |
| 29-Jan-13 5:22 PM View: | Livingston Randall S Director | Genomic Health Inc. (GHDX) | 28-Jan-13 | Market Option Sale | 2,000 | $28.77 | $57,543.00 | (25%) 8.15K to 6.15K | < 1% |
| 11-Jan-13 7:29 PM View: | Cole G Bradley COO | Genomic Health Inc. (GHDX) | 09-Jan-13 | Market Option Sale | 2,500 | $27.88 | $69,694.00 | (15%) 16.59K to 14.09K | (3%) |
| 11-Jan-13 7:31 PM View: | Schorno Dean L CFO | Genomic Health Inc. (GHDX) | 09-Jan-13 | Option Exercise | 2,625 | $9.39 | $24,648.80 | 11% 23.5K to 26.13K | |
| 11-Jan-13 7:29 PM View: | Cole G Bradley COO | Genomic Health Inc. (GHDX) | 09-Jan-13 | Option Exercise | 2,500 | $1.33 | $3,325.00 | 18% 14.09K to 16.59K | |
| 11-Jan-13 7:31 PM View: | Schorno Dean L CFO | Genomic Health Inc. (GHDX) | 09-Jan-13 | Market Option Sale | 2,625 | $28.00 | $73,500.00 | (10%) 26.13K to 23.5K | (3%) |
| 03-Jan-13 5:06 PM View: | Cohen Fred E Director | Genomic Health Inc. (GHDX) | 01-Jan-13 | Grant | 367 | $27.24 | $9,997.08 | < 1% 65.66K to 66.03K | 6% |
